Hubei Jumpcan Pharmaceutical Co Ltd (600566) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.018x

Based on the latest financial reports, Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-243.75 Million ≈ $-35.67 Million USD) by net assets (CN¥13.86 Billion ≈ $2.03 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hubei Jumpcan Pharmaceutical Co Ltd (600566) net asset quality to measure how much of total assets are equity-financed.

Hubei Jumpcan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Hubei Jumpcan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Hubei Jumpcan Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Hubei Jumpcan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hubei Jumpcan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Fosun International Limited
F:FNI
0.045x
CGN Power Co Ltd
F:94C
0.064x
ENAGAS A.A. ADR1/2/EO150
F:EG40
0.014x
QL Resources Bhd
KLSE:7084
0.056x
Masan Group Corp
VN:MSN
0.032x
Jointown Pharmaceutical Group Co Ltd
SHG:600998
0.015x
WSFS Financial Corporation
NASDAQ:WSFS
0.045x
Honeywell Automation India Limited
NSE:HONAUT
0.054x

Annual Cash Flow Conversion Efficiency for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)

The table below shows the annual cash flow conversion efficiency of Hubei Jumpcan Pharmaceutical Co Ltd from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Hubei Jumpcan Pharmaceutical Co Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥14.63 Billion
≈ $2.14 Billion
CN¥1.20 Billion
≈ $175.35 Million
0.082x -44.59%
2024-12-31 CN¥14.73 Billion
≈ $2.15 Billion
CN¥2.18 Billion
≈ $318.48 Million
0.148x -42.96%
2023-12-31 CN¥13.37 Billion
≈ $1.96 Billion
CN¥3.46 Billion
≈ $506.89 Million
0.259x +12.24%
2022-12-31 CN¥11.35 Billion
≈ $1.66 Billion
CN¥2.62 Billion
≈ $383.51 Million
0.231x +11.28%
2021-12-31 CN¥9.13 Billion
≈ $1.34 Billion
CN¥1.89 Billion
≈ $277.20 Million
0.207x -9.61%
2020-12-31 CN¥7.76 Billion
≈ $1.14 Billion
CN¥1.78 Billion
≈ $260.72 Million
0.230x -34.77%
2019-12-31 CN¥6.10 Billion
≈ $893.27 Million
CN¥2.15 Billion
≈ $314.27 Million
0.352x +12.35%
2018-12-31 CN¥5.46 Billion
≈ $798.65 Million
CN¥1.71 Billion
≈ $250.10 Million
0.313x +15.96%
2017-12-31 CN¥4.40 Billion
≈ $644.12 Million
CN¥1.19 Billion
≈ $173.95 Million
0.270x +9.06%
2016-12-31 CN¥3.69 Billion
≈ $539.60 Million
CN¥913.10 Million
≈ $133.61 Million
0.248x +4.07%
2015-12-31 CN¥2.71 Billion
≈ $396.97 Million
CN¥645.48 Million
≈ $94.45 Million
0.238x -11.41%
2014-12-31 CN¥2.29 Billion
≈ $335.68 Million
CN¥616.11 Million
≈ $90.16 Million
0.269x +7.78%
2013-12-31 CN¥1.15 Billion
≈ $168.63 Million
CN¥287.16 Million
≈ $42.02 Million
0.249x +352.79%
2012-12-31 CN¥490.80 Million
≈ $71.82 Million
CN¥27.01 Million
≈ $3.95 Million
0.055x +6950.17%
2011-12-31 CN¥526.82 Million
≈ $77.09 Million
CN¥411.24K
≈ $60.18K
0.001x -99.21%
2010-12-31 CN¥520.27 Million
≈ $76.13 Million
CN¥51.13 Million
≈ $7.48 Million
0.098x +924.94%
2009-12-31 CN¥512.85 Million
≈ $75.05 Million
CN¥4.92 Million
≈ $719.55K
0.010x -78.95%
2008-12-31 CN¥506.18 Million
≈ $74.07 Million
CN¥23.05 Million
≈ $3.37 Million
0.046x -38.13%
2007-12-31 CN¥498.83 Million
≈ $72.99 Million
CN¥36.72 Million
≈ $5.37 Million
0.074x +743.02%
2006-12-31 CN¥485.82 Million
≈ $71.09 Million
CN¥4.24 Million
≈ $620.77K
0.009x -93.38%
2005-12-31 CN¥480.25 Million
≈ $70.28 Million
CN¥63.38 Million
≈ $9.27 Million
0.132x +265.74%
2004-12-31 CN¥473.92 Million
≈ $69.35 Million
CN¥-37.74 Million
≈ $-5.52 Million
-0.080x -1755.48%
2003-12-31 CN¥466.47 Million
≈ $68.26 Million
CN¥2.24 Million
≈ $328.32K
0.005x -89.96%
2002-12-31 CN¥459.05 Million
≈ $67.17 Million
CN¥22.00 Million
≈ $3.22 Million
0.048x +190.19%
2001-12-31 CN¥449.57 Million
≈ $65.79 Million
CN¥7.43 Million
≈ $1.09 Million
0.017x -90.25%
2000-12-31 CN¥140.01 Million
≈ $20.49 Million
CN¥23.73 Million
≈ $3.47 Million
0.169x --

About Hubei Jumpcan Pharmaceutical Co Ltd

SHG:600566 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.65 Billion
CN¥24.97 Billion CNY
Market Cap Rank
#4349 Global
#675 in China
Share Price
CN¥27.09
Change (1 day)
+3.32%
52-Week Range
CN¥22.19 - CN¥28.95
All Time High
CN¥44.43
About

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of drugs in China. The company offers Chinese traditional and Western medicines, daily use chemicals, and medicine health products in various formulations. Its products are used in the areas of detoxification, digestive system, pediatric, respiratory system, nervous system, anti-infection, cardiovasc… Read more